Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01162278 · ClinicalTrials.gov registry record · Phase 1
Stereotactic Body Radiation Therapy (SBRT) for Patients With Hepatic Metastases
A Phase 1 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT01162278 is a Phase 1 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 60 participants.
The verdict
NCT01162278, a Phase 1 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
Patients that have had staging studies identifying them as AJCC stage IV with up to five liver metastases will be considered for the study. About 60 patients will take part in this study at UT southwestern, Parkland Health \& Hospital System, and Methodist Richardson Cancer Center. There are four dose cohorts for this study and each cohort will enroll a minimum of 7 to a maximum of 15 patients depending on tolerance of therapy. The treatment period will last for approximately 1 day and the follow-up portion of the study will last 5 years.
Interventions
- RADIATION SBRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2010-07 |
| Est. Completion | 2017-11-25 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01162278
The ClinicalTrials.gov registry entry for NCT01162278 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SBRT is the first listed.
NCT01162278 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01162278 about?
NCT01162278 is a clinical study titled "Stereotactic Body Radiation Therapy (SBRT) for Patients With Hepatic Metastases". Patients that have had staging studies identifying them as AJCC stage IV with up to five liver metastases will be considered for the study. About 60 patients will take part in this study at UT southwestern, Parkland Health \& Hospital System, and Methodist Richardson Cancer Center. There are four do...
What is the current status of trial NCT01162278?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2010-07. Estimated completion is 2017-11-25.
What interventions are being tested in trial NCT01162278?
The interventions under investigation include: SBRT (RADIATION).
Who is sponsoring clinical trial NCT01162278?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.